Clinical Trial Data Analysis – Does A Globally Distributed Model Through Outsourcing and Offshoring Help Biopharmaceutical Companies and How?

CHITRA LELE | May 21, 2015

article image
Over the past decade BPOs, KPOs, SPOs and CROs have been instrumental in addressing industry challenges by providing clinical development services such as clinical operations.

Spotlight

InfoMedix

InfoMedix is Australia's leading digitised medical records solution. Founded in 2000, InfoMedix is now installed in over 30 hospitals around Australia. The key product is a digital medical record solution that consolidates patient centric information to become the complete medical record. Key to this technology is an innovative scanning solution which allows hospitals to digitise the traditional paper based medical record.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 17, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Spotlight

InfoMedix

InfoMedix is Australia's leading digitised medical records solution. Founded in 2000, InfoMedix is now installed in over 30 hospitals around Australia. The key product is a digital medical record solution that consolidates patient centric information to become the complete medical record. Key to this technology is an innovative scanning solution which allows hospitals to digitise the traditional paper based medical record.

Events